A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
Figure 7.Correlation between the expressions of BCCGs and sensitivity of potential anticancer drugs: The relationship between the IC50 of various medications and the risk score.